Amedeo Smart

Free Medical Literature Service

 

Amedeo

Autoimmune Disorders
  Free Subscription

Articles published in
PLoS One
    January 2025
  1. CARRASCO S, Liphaus BL, Peixoto TV, Lima TM, et al
    Early neutrophil activation and NETs release in the pristane-induced lupus mice model.
    PLoS One. 2025;20:e0306943.
    >> Share

  2. SIEBALD F, Grittner U, Otto C, Bereuter C, et al
    Ultrasound pupillometry for the detection of a relative afferent pupillary defect (RAPD): Systematic evaluation in patients with optic neuritis and comparison with infrared video pupillometry.
    PLoS One. 2025;20:e0315712.
    >> Share

  3. XU Y, Wang Z, Jia T, Liang S, et al
    Exploring potential drug targets for SLE through Mendelian randomization and network pharmacology.
    PLoS One. 2025;20:e0316481.
    >> Share

  4. KATZ A, Shulkin A, Fortier MA, Yardley JE, et al
    Strategies to reduce hyperglycemia-related anxiety in elite athletes with type 1 diabetes: A qualitative analysis.
    PLoS One. 2025;20:e0313051.
    >> Share

  5. RAO GA, Shoaibi A, Makadia R, Hardin J, et al
    CohortDiagnostics: Phenotype evaluation across a network of observational data sources using population-level characterization.
    PLoS One. 2025;20:e0310634.
    >> Share

  6. TRAN HT, Rodprasert W, Padeta I, Oontawee S, et al
    Establishment of subcutaneous transplantation platform for delivering induced pluripotent stem cell-derived insulin-producing cells.
    PLoS One. 2025;20:e0318204.
    >> Share

  7. OROMO DO
    Pediatric Diabetic Ketoacidosis (PDKA) among newly diagnosed diabetic patients at Dilla University Hospital, Dilla, Ethiopia: Prevalence and predictors.
    PLoS One. 2025;20:e0314433.
    >> Share

  8. VAN REENEN EC, van Nistelrooij IAM, Visser LH, de Beukelaar JWK, et al
    The liminal space between hope and grief: The phenomenon of uncertainty as experienced by people living with relapsing-remitting multiple sclerosis.
    PLoS One. 2025;20:e0315501.
    >> Share

  9. ZHANG S, Hu W, Tang Y, Chen X, et al
    Identification and validation of key autophagy-related genes in lupus nephritis by bioinformatics and machine learning.
    PLoS One. 2025;20:e0318280.
    >> Share

  10. ZHAO YF, Chaw JK, Ang MC, Tew Y, et al
    A safe-enhanced fully closed-loop artificial pancreas controller based on deep reinforcement learning.
    PLoS One. 2025;20:e0317662.
    >> Share

  11. IMAN K, Akter L, Rahman MM, Laila K, et al
    Treatment of refractory poly articular course juvenile idiopathic arthritis with tofacitinib: Extended experience from Bangladesh.
    PLoS One. 2025;20:e0312174.
    >> Share

  12. JAALKHOROL M, Dashtseren A, Magnaibayar G, Bat-Orgil B, et al
    Factors associated with vitamin D levels in Mongolian patients with multiple sclerosis.
    PLoS One. 2025;20:e0317279.
    >> Share

  13. YE W, Ding Y, Li M, Tian Z, et al
    Drug-induced autoimmune-like hepatitis: A disproportionality analysis based on the FAERS database.
    PLoS One. 2025;20:e0317680.
    >> Share

  14. JOERNS EK, Ghebranious MA, Adams TN, Makris UE, et al
    Evaluation of comorbidity burden on disease progression and mortality in patients with interstitial pneumonia with autoimmune features: A retrospective cohort study.
    PLoS One. 2025;20:e0316762.
    >> Share

  15. DAVE S, Rahi JS, Petrushkin H, Testi I, et al
    UVESCREEN1: A randomised feasibility study of imaging-based uveitis screening for children with juvenile idiopathic arthritis- Study Protocol.
    PLoS One. 2025;20:e0316410.
    >> Share

  16. MAMELI C, Valsecchi C, Cereda D, Scarioni S, et al
    Type 1 diabetes incidence during COVID-19 pandemic has not been influenced by COVID-19 vaccination in northern Italy region, Lombardy.
    PLoS One. 2025;20:e0316340.
    >> Share

  17. MCCARTHY EM, Dinneen SF, Byrne M, Morrissey EC, et al
    Perceptions and experiences of young adults and their healthcare team of the D1 Now type 1 diabetes intervention.
    PLoS One. 2025;20:e0316345.
    >> Share

  18. COSTA V, Aluan K, Schiavetti I, Bason C, et al
    Study protocol: Exploratory trial of Forza, an osmotin-based nutraceutical as adjuvant for the treatment of progressive multiple sclerosis.
    PLoS One. 2025;20:e0311214.
    >> Share

  19. KHDAIR SI, Al-Khareisha L, Abusara OH, Hammad AM, et al
    HLA-class II genes association with multiple sclerosis: An immunogenetic prediction among multiple sclerosis Jordanian patients.
    PLoS One. 2025;20:e0318824.
    >> Share

  20. DE DIOS PEREZ B, Booth V, das Nair R, Evangelou N, et al
    Vocational rehabilitation for people with multiple sclerosis in the national health service of the United Kingdom: A realist evaluation.
    PLoS One. 2025;20:e0319287.
    >> Share

  21. TATULASHVILI S, Dreves B, Cosson E, Meyer L, et al
    First validity testing of GluciQuizz, a French self-questionnaire evaluating carb-counting for patients with type 1 diabetes.
    PLoS One. 2025;20:e0318746.
    >> Share

  22. CHEN S, Cui X, Chen Y, Guo X, et al
    Biologic therapies for the treatment of large vessel vasculitis: A systematic review and meta-analysis.
    PLoS One. 2025;20:e0314566.
    >> Share

  23. ISLAM MZ, Zimmerman S, Lindahl A, Weidanz J, et al
    Single-cell RNA-seq reveals disease-specific CD8+ T cell clonal expansion and a high frequency of transcriptionally distinct double-negative T cells in diabetic NOD mice.
    PLoS One. 2025;20:e0317987.
    >> Share

  24. SHIMIZU S, Tanaka A, Matsuyama N, Kinoshita F, et al
    Randomised, double-blind study to evaluate the efficacy of rituximab in the treatment of idiopathic membranous nephropathy: A clinical trial protocol.
    PLoS One. 2025;20:e0320070.
    >> Share

  25. RUSSO JS, Mahoney T, Kokorin K, Reynolds A, et al
    Towards developing brain-computer interfaces for people with Multiple Sclerosis.
    PLoS One. 2025;20:e0319811.
    >> Share

  26. ETEMADIFAR M, Shoeib S, Salari M, Etemadifar M, et al
    Gynecologic health of women with multiple sclerosis: An overview on the current status and findings of Pap tests in a low-income setting.
    PLoS One. 2025;20:e0320069.
    >> Share

  27. WANG S, Ka M, Wu W
    Does hydroxychloroquine reduce the risk of infection in patients with systemic lupus erythematosus? a systematic review and meta-analysis.
    PLoS One. 2025;20:e0320353.
    >> Share

  28. REN Y, Chen W, Lin Y, Wang Z, et al
    Identification of glucocorticoid-related genes in systemic lupus erythematosus using bioinformatics analysis and machine learning.
    PLoS One. 2025;20:e0319737.
    >> Share

  29. SALAME G, Hakim V, Dagher C, Daou RM, et al
    Immunotherapy as a treatment for type 1 diabetes mellitus in children and young adults: A comprehensive systematic review and meta-analysis.
    PLoS One. 2025;20:e0321727.
    >> Share

  30. GOETTFRIED E, Barket R, Hershman R, Delazer M, et al
    Face exploration, emotion recognition, and emotional enhancement of memory in relapsing-remitting multiple sclerosis.
    PLoS One. 2025;20:e0319967.
    >> Share

  31. SU Y, Li X, Wu PD, Zhang YL, et al
    The Association between PTPN22 SNPs and susceptibility to type 1 diabetes: An updated meta-analysis.
    PLoS One. 2025;20:e0321624.
    >> Share

  32. SCHLAEGER S, Muhlau M, Gilbert G, Vavasour I, et al
    Sensitivity of multi-parametric quantitative magnetic resonance imaging for multiple sclerosis pathology.
    PLoS One. 2025;20:e0318415.
    >> Share

  33. WU Q, Chen Y, Shen M, Cai Y, et al
    Moderate to severe chronic arteriolar lesions is an independent risk factor for adverse renal outcomes in IgA nephropathy.
    PLoS One. 2025;20:e0320635.
    >> Share

  34. ZANGENEH Z, Rostamian M, Motamedi H, Alvandi A, et al
    The potential effectiveness of probiotics in reducing multiple sclerosis progression in preclinical and clinical studies: A worldwide systematic review and meta-analysis.
    PLoS One. 2025;20:e0319755.
    >> Share

  35. GUTIERREZ-GUTIERREZ G, Gomez-Ballesteros R, Sotoca J, Ares A, et al
    Assessing therapeutic decisions in generalized myasthenia gravis: Study protocol.
    PLoS One. 2025;20:e0322168.
    >> Share

  36. YIN J, Hou Y, Wang C, Qin C, et al
    Clinical outcomes of baricitinib in patients with systemic lupus erythematosus: Pooled analysis of SLE-BRAVE-I and SLE-BRAVE-II trials.
    PLoS One. 2025;20:e0320179.
    >> Share

  37. HE S, Nie H, Yin X, Zhong Z, et al
    Identification of key extracellular proteins as the potential biomarkers in thyroid eye disease.
    PLoS One. 2025;20:e0322415.
    >> Share

  38. MENG H, Wang S, Gu L, Wang Y, et al
    Potential drug targets for Neuromyelitis optica spectrum disorders (NMOSD): A Mendelian randomization analysis.
    PLoS One. 2025;20:e0322098.
    >> Share

  39. ALAZWARI A, Tafakori L, Johnstone A, Abdollahian M, et al
    Modeling the number of new cases of childhood type 1 diabetes using Poisson regression and machine learning methods; a case study in Saudi Arabia.
    PLoS One. 2025;20:e0321480.
    >> Share

  40. ALMOMANI BA, Elayyan RN, Al-Shatnawi SF
    Type 1 diabetes mellitus in children: Patient reported outcomes.
    PLoS One. 2025;20:e0322882.
    >> Share

  41. MCKECHNIE V, Avari P, Eng PC, Unsworth R, et al
    The experiences of high-risk young adults with type 1 diabetes transitioning to real-time continuous glucose monitoring - A thematic analysis.
    PLoS One. 2025;20:e0320702.
    >> Share

  42. HERMINE O, Gros L, Tran TA, Loussaief L, et al
    Tyrosine kinase inhibitor, masitinib, limits neuronal damage, as measured by serum neurofilament light chain concentration in a model of neuroimmune-driven neurodegenerative disease.
    PLoS One. 2025;20:e0322199.
    >> Share

  43. MITTAL R, McKenna K, Lemos JRN, Juneja S, et al
    Therapeutic potential of anti-thymocyte globulin in type 1 diabetes: A systematic review.
    PLoS One. 2025;20:e0323642.
    >> Share

  44. GUAN X, Liu W, Gao T, Jin W, et al
    Anti-beta2GPI/beta2GPI complex promotes thrombosis by activating the P2Y2/MAPKs pathway to increase human neutrophil peptides.
    PLoS One. 2025;20:e0322447.
    >> Share

  45. OMER N, Wilczynski E, Zlotzover S, Helft C, et al
    Validation of a data-driven multicomponent T2 analysis for quantifying myelin content in the cuprizone mouse model of multiple sclerosis.
    PLoS One. 2025;20:e0323614.
    >> Share

  46. YOUNG G, Nguyen VS, Howlett-Prieto Q, Abuaf AF, et al
    Validation of retroactively derived T1 relaxation values from 3D T1-weighted images with clinical and MRI measures of disability in multiple sclerosis.
    PLoS One. 2025;20:e0323898.
    >> Share

  47. OZTURK HK, Slanar O, Michalickova D
    Safety and efficacy of antigen-specific therapeutic approaches for multiple sclerosis: Systematic review.
    PLoS One. 2025;20:e0320814.
    >> Share

  48. LAI L, Wu C, Li X, Rong Y, et al
    Urinary MCP-1 and VCAM-1 as non-invasive biomarkers for the diagnosis and activity assessment of lupus nephritis.
    PLoS One. 2025;20:e0323334.
    >> Share

  49. KRULL F, Hosseini S, Bleyer M, Brenig B, et al
    Findings from transcriptomics and immunohistochemistry indicate an autoimmune disease targeting brainstem inhibitory interneurons in bovine spastic paresis.
    PLoS One. 2025;20:e0324633.
    >> Share

  50. MAKHLOUF Y, Ayed HB, Miladi S, Boussaa H, et al
    Effect of biologic treatments on growth in children with juvenile idiopathic arthritis: A systematic review.
    PLoS One. 2025;20:e0324440.
    >> Share

  51. RAINA M, Shah R, Hu J, Pember B, et al
    The global health burden of pediatric chronic kidney disease: An analysis of the Global Burden of Disease database from 1990 to 2021.
    PLoS One. 2025;20:e0323257.
    >> Share

  52. JARAB AS, Al-Qerem WA, Alqudah S, Alzoubi KH, et al
    Insulin-self administration among individuals with diabetes: Implications for improved practices.
    PLoS One. 2025;20:e0324846.
    >> Share

  53. WULLER S, Singer NG, Lewis C, Karlson EW, et al
    Severity of acute SARS-CoV-2 infection and risk of new-onset autoimmune disease: A RECOVER initiative study in nationwide U.S. cohorts.
    PLoS One. 2025;20:e0324513.
    >> Share

  54. ANGENETE OW, Haustreis J, Aune LK, Lundestad A, et al
    Children as controls in research; The voice of the volunteer.
    PLoS One. 2025;20:e0325069.
    >> Share

  55. JEYABALAN A, Jhaveri KD, Bunke M, Briggs JA, et al
    Clinical study outcomes in IgA nephropathy: A systematic literature review and narrative synthesis.
    PLoS One. 2025;20:e0323530.
    >> Share

  56. JIANG W, Peng X, Dong L, Wu L, et al
    Predictors of neuropsychiatric manifestations in pediatric patients with lupus.
    PLoS One. 2025;20:e0325915.
    >> Share

  57. BLOIS SL, Cuq BY, Bienzle D
    Lymphocyte immunophenotype in dogs with immune-mediated hematologic disease.
    PLoS One. 2025;20:e0326341.
    >> Share

  58. DE DIOS PEREZ B, Kendrick D, das Nair R, Evangelou N, et al
    Optimising access to vocational rehabilitation through multiple sclerosis charities: Protocol for a feasibility randomised controlled trial.
    PLoS One. 2025;20:e0325570.
    >> Share

  59. BOZZI S, Umarje S, Hawaldar K, Tyma J, et al
    Prevalence and incidence of primary autoimmune hemolytic anemia and cold agglutinin disease in the United States, 2016-2023.
    PLoS One. 2025;20:e0323843.
    >> Share

  60. MOHAMED YM, Mancera J, Brandenberg A, Fischli S, et al
    Personalized machine learning models for noninvasive hypoglycemia detection in people with type 1 diabetes using a smartwatch: Insights into feature importance during waking and sleeping times.
    PLoS One. 2025;20:e0325956.
    >> Share

  61. MARTIN-AVILA J, Rodriguez-Jimenez E, Valero-Moreno S, Gil-Gomez JA, et al
    Intervention through an intelligent technological platform for socio-emotional development and health promotion in adolescents with Type 1 Diabetes Mellitus (emoTICare): A study protocol for randomized controlled trial.
    PLoS One. 2025;20:e0325763.
    >> Share

  62. CARAZO A, Paclikova M, Fadraersada J, Alva-Gallegos R, et al
    Type 1 diabetes mellitus patients had lower total vitamin K levels and increased sensitivity to direct anticoagulants.
    PLoS One. 2025;20:e0326580.
    >> Share

  63. TAKAHASHI K, Takeishi C, Tsutsumi C, Nakao T, et al
    Exploring the relationship between self-care agency and quality of life in adults with diabetes: A cross-sectional study.
    PLoS One. 2025;20:e0326783.
    >> Share

  64. WANG K, Xu P, Lu J, Ji X, et al
    Circadian rhythm genes and immune cell infiltration in myasthenia gravis: A comprehensive analysis.
    PLoS One. 2025;20:e0327829.
    >> Share

  65. GONG X, Xue X, Gao R, Feng S, et al
    Application of telemedicine in fatigue management for patients with multiple sclerosis: A scoping review.
    PLoS One. 2025;20:e0327563.
    >> Share

  66. MOTOKI Y, Kaneshige R, Fujieda Y, Oku K, et al
    A preliminary report on the feasibility of regression-based alignment of diagnostic thresholds for harmonized use of international classification criteria for antiphospholipid syndrome.
    PLoS One. 2025;20:e0328229.
    >> Share

  67. LIM J, Kim YJ, Kim S, Shim JH, et al
    Impact of metabolic dysfunction-associated steatotic liver disease on hepatocellular carcinoma risk in autoimmune hepatitis.
    PLoS One. 2025;20:e0325066.
    >> Share

  68. HO MKH, Santhireswaran A, Gomes T, Mamdani M, et al
    Comparative effectiveness and safety of insulin reference biologics versus biosimilars for types 1 and 2 diabetes mellitus: Protocol for a systematic review of real-world studies.
    PLoS One. 2025;20:e0329299.
    >> Share

  69. CARR ALJ, Shah R, Marfil-Garza BA, Lam A, et al
    Sequential islet transplants for type 1 diabetes are not associated with sustained or cumulative increases in hepatic portal venous pressure.
    PLoS One. 2025;20:e0329074.
    >> Share

  70. ATTAR A, Alshaikh H, Alharbi G, Aletani T, et al
    Outcomes of myasthenia gravis patients admitted to the Intensive Care Unit: Experience from a tertiary care center in Saudi Arabia.
    PLoS One. 2025;20:e0328648.
    >> Share

  71. MIRMOSAYYEB O, Vaheb S, Afshari-Safavi A, Shaygannejad A, et al
    Long-term effects of air pollution on the incidence and progression of multiple sclerosis: A population cohort study in Isfahan, Iran.
    PLoS One. 2025;20:e0327635.
    >> Share

  72. RASMUSSEN MGB, Just-Ostergaard E, Stidsen JV, Willaing I, et al
    What is the impact of structural changes in society on diabetes self-management and trajectories of HbA1c? A cohort study before, during and after the COVID-19 pandemic in people with diabetes treated at outpatient clinics.
    PLoS One. 2025;20:e0329394.
    >> Share

  73. ZHOU J, Zhang Z, Zhou K, Zhou L, et al
    PLA2R1 and HLA-DQA1 SNP in patients with primary membranous nephropathy.
    PLoS One. 2025;20:e0328234.
    >> Share

  74. AKAMINE H, Uzawa A, Kuwabara S, Suzuki S, et al
    Predicting achievement of clinical goals using machine learning in myasthenia gravis.
    PLoS One. 2025;20:e0330044.
    >> Share

  75. VINCENTINI O, Pricci F, Silano M, Agrimi U, et al
    Study protocol of D1Ce Screen: A pilot project of the Italian national screening program for type 1 diabetes and coeliac disease in the paediatric population.
    PLoS One. 2025;20:e0328624.
    >> Share

  76. URASHIMA K, Ichinose K, Ishimaru H, Kumazaki H, et al
    Novel imaging diagnosis of neuropsychiatric systemic lupus erythematosus using topological data analysis: A retrospective study.
    PLoS One. 2025;20:e0329859.
    >> Share

  77. NGUYEN MTT, Le MH, Vu MN, Baumann K, et al
    Clinical and quality of life improvement after bilastine treatment among patients with autoimmune chronic spontaneous urticaria.
    PLoS One. 2025;20:e0326445.
    >> Share

  78. GOEZ-MORA JE, Arbelaez-Cordoba N, Balcazar-Morales N, Rivadeneira PS, et al
    Validation in diabetic rats of a fully automated insulin delivery system based on impulsive offset-free MPC control.
    PLoS One. 2025;20:e0330121.
    >> Share

  79. AL-EITAN L, Darabseh S
    VDR gene variants FokI and ApaI: Factors associated with susceptibility to multiple sclerosis.
    PLoS One. 2025;20:e0332473.
    >> Share

  80. LI L, Olcer M, Wang Z, Song Y, et al
    IFN-beta therapy rescues dysregulated IFN-stimulated proteins, serum cytokines, and neurotrophic factors in multiple sclerosis: Multiplex analysis of short-term and long-term IFN responses.
    PLoS One. 2025;20:e0330867.
    >> Share

    January 2024
  81. XUE H, Zeng L, He H, Xu D, et al
    Effects of acupuncture treatment for myasthenia gravis: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0291685.
    >> Share

  82. EKMAN L, Dahlin LB, Andersson GS, Lindholm E, et al
    Diagnostic contribution of multi-frequency vibrometry to detection of peripheral neuropathy in type 1 diabetes mellitus compared with nerve conduction studies.
    PLoS One. 2024;19:e0296661.
    >> Share

  83. MORCIANO C, Spila Alegiani S, Menniti Ippolito F, Belleudi V, et al
    Post-marketing active surveillance of Guillain Barre Syndrome following COVID-19 vaccination in persons aged >/=12 years in Italy: A multi-database self-controlled case series study.
    PLoS One. 2024;19:e0290879.
    >> Share

  84. DASGUPTA SK, Gollamudi J, Rivera S, Poche RA, et al
    beta2-glycoprotein I promotes the clearance of circulating mitochondria.
    PLoS One. 2024;19:e0293304.
    >> Share

  85. TOLF A, Gauffin H, Burman J, Landtblom AM, et al
    Experiences of being treated with autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: A qualitative interview study.
    PLoS One. 2024;19:e0297573.
    >> Share

  86. YANG H, Chen Z, Huang J, Li S, et al
    AWD-stacking: An enhanced ensemble learning model for predicting glucose levels.
    PLoS One. 2024;19:e0291594.
    >> Share

  87. DADVAR A, Jameie M, Azizmohammad Looha M, Parsaei M, et al
    Potential efficacy of caffeine ingestion on balance and mobility in patients with multiple sclerosis: Preliminary evidence from a single-arm pilot clinical trial.
    PLoS One. 2024;19:e0297235.
    >> Share

  88. JAKA S, Singh S, Vashist S, Pokhrel S, et al
    Pediatric anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis: Exploring psychosis, related risk factors, and hospital outcomes in a nationwide inpatient sample: A cross-sectional study.
    PLoS One. 2024;19:e0296870.
    >> Share

  89. MITTAL R, McKenna K, Keith G, Lemos JRN, et al
    A systematic review of the association of Type I diabetes with sensorineural hearing loss.
    PLoS One. 2024;19:e0298457.
    >> Share

  90. SHEMIRANI F, Pingel WR, Titcomb TJ, Salari-Moghaddam A, et al
    The effect of dietary interventions on inflammatory biomarkers among people with multiple sclerosis: A protocol for systematic review and meta-analysis of randomized controlled trials.
    PLoS One. 2024;19:e0297510.
    >> Share

  91. JEONG HS, Chun BC
    COVID-19 vaccine safety: Background incidence rates of anaphylaxis, myocarditis, pericarditis, Guillain-Barre Syndrome, and mortality in South Korea using a nationwide population-based cohort study.
    PLoS One. 2024;19:e0297902.
    >> Share

  92. LIU X, Xue J, Li T, Wu Q, et al
    Quantitative detection and prognostic value of antibodies against M-type phospholipase A2 receptor and its cysteine-rich ricin domain and C-type lectin domains 1 and 6-7-8 in patients with idiopathic membranous nephropathy.
    PLoS One. 2024;19:e0298269.
    >> Share

  93. SMUDJA M, Milenkovic T, Minakovic I, Zdravkovic V, et al
    Self-care activities in pediatric patients with type 1 diabetes mellitus.
    PLoS One. 2024;19:e0300055.
    >> Share

  94. TRAN TT, Nguyen TN, Dauvilliers Y, Liblau R, et al
    Absence of specific autoantibodies in patients with narcolepsy type 1 as indicated by an unbiased random peptide-displayed phage screening.
    PLoS One. 2024;19:e0297625.
    >> Share

  95. JOZEF M, Locatelli I, Brecl Jakob G, Savsek L, et al
    Psychometric evaluation of the 5-item Medication Adherence Report Scale questionnaire in persons with multiple sclerosis.
    PLoS One. 2024;19:e0294116.
    >> Share

  96. LIU P, Luo J, Zhao L, Fu Q, et al
    Causal relationship between several autoimmune diseases and renal malignancies: A two-sample mendelian randomization study.
    PLoS One. 2024;19:e0297861.
    >> Share

  97. FLOYD L, Dhaygude A, Mitra S, Rowland C, et al
    Developing a disease-specific patient reported outcome measure to enhance understanding of the lived experiences of ANCA associated vasculitis: A protocol paper.
    PLoS One. 2024;19:e0298796.
    >> Share

  98. LIU Z, Fan T, Mo X, Kan J, et al
    Association between multiple sclerosis and cancer risk: A two-sample Mendelian randomization study.
    PLoS One. 2024;19:e0298271.
    >> Share

  99. CARATIS F, Opielka M, Hausmann M, Velasco-Estevez M, et al
    The proton-sensing receptors TDAG8 and GPR4 are differentially expressed in human and mouse oligodendrocytes: Exploring their role in neuroinflammation and multiple sclerosis.
    PLoS One. 2024;19:e0283060.
    >> Share

  100. LEREIM RR, Nytrova P, Guldbrandsen A, Havrdova EK, et al
    Natalizumab promotes anti-inflammatory and repair effects in multiple sclerosis.
    PLoS One. 2024;19:e0300914.
    >> Share

  101. BRNABIC AJM, Curtis SE, Johnston JA, Lo A, et al
    Incidence of type 2 diabetes, cardiovascular disease and chronic kidney disease in patients with multiple sclerosis initiating disease-modifying therapies: Retrospective cohort study using a frequentist model averaging statistical framework.
    PLoS One. 2024;19:e0300708.
    >> Share

  102. IMRAISH A, Abu Thiab T, Alsalem M, Dahbour S, et al
    The neuroprotective effect of human primary astrocytes in multiple sclerosis: In vitro model.
    PLoS One. 2024;19:e0300203.
    >> Share

  103. ESIASON DC, Ciesinski N, Nurse CN, Erler W, et al
    The psychological burden of NMOSD - a mixed method study of patients and caregivers.
    PLoS One. 2024;19:e0300777.
    >> Share

  104. KAMPAITE A, Gustafsson R, York EN, Foley P, et al
    Brain connectivity changes underlying depression and fatigue in relapsing-remitting multiple sclerosis: A systematic review.
    PLoS One. 2024;19:e0299634.
    >> Share

  105. MA J, Xing J, Zhang Y, Liu G, et al
    Efficacy and safety of biologic agents for IgA nephropathy: A protocol for systematic review and meta-analysis.
    PLoS One. 2024;19:e0298732.
    >> Share

  106. JANSSENS N, Van Wilder L, Van Hecke A, Van Hoorenbeeck K, et al
    COCCOS study: Developing a transition program for adolescents with chronic conditions using Experience-Based Co-Design. A study protocol.
    PLoS One. 2024;19:e0298571.
    >> Share

  107. MEDINA-RAMIREZ SA, Soriano-Moreno DR, Tuco KG, Castro-Diaz SD, et al
    Prevalence and incidence of diabetic retinopathy in patients with diabetes of Latin America and the Caribbean: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0296998.
    >> Share

  108. YAGHOOBPOOR S, Fathi M, Vakili K, Sayehmiri F, et al
    Insulin-like growth factor-1 (IGF-1) levels in multiple sclerosis patients: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0297091.
    >> Share

  109. LOMER NB, Asalemi KA, Saberi A, Sarlak K, et al
    Predictors of multiple sclerosis progression: A systematic review of conventional magnetic resonance imaging studies.
    PLoS One. 2024;19:e0300415.
    >> Share

  110. LI H, Huntington S, Gross C, Wang SY, et al
    Immunotherapy utilization patterns in patients with advanced cancer and autoimmune disease.
    PLoS One. 2024;19:e0300789.
    >> Share

  111. DE RIDDER F, Braspenning R, Ordonez JS, Klarenbeek G, et al
    Early feasibility study with an implantable near-infrared spectroscopy sensor for glucose, ketones, lactate and ethanol.
    PLoS One. 2024;19:e0301041.
    >> Share

  112. SCAGNELLATO L, Cozzi G, Prosepe I, Lorenzin M, et al
    Relapses of juvenile idiopathic arthritis in adulthood: A monocentric experience.
    PLoS One. 2024;19:e0298679.
    >> Share

  113. SVENSSON AK, Dahlin LB, Rydberg M, Perez R, et al
    Surgery for carpal tunnel syndrome in patients with and without diabetes-Is there a difference in the frequency of surgical procedures?
    PLoS One. 2024;19:e0302219.
    >> Share

  114. ZHOU K, Zhou J, Zhou L, Xue J, et al
    Predictive value of the domain specific PLA2R antibodies for clinical remission in patients with primary membranous nephropathy: A retrospective study.
    PLoS One. 2024;19:e0302100.
    >> Share

  115. UEDA H, Joh K, Ueda Y, Marumoto H, et al
    Accelerated involution of germinal center in palatine tonsils in IgA nephropathy.
    PLoS One. 2024;19:e0301853.
    >> Share

  116. LEE YH, Song GG
    Platelet-to-lymphocyte ratio as a biomarker of systemic inflammation in systemic lupus erythematosus: A meta-analysis and systematic review.
    PLoS One. 2024;19:e0303665.
    >> Share

  117. ZHAI Y, Tian H, Zhang W, Sun S, et al
    Genome-wide analysis of long noncoding RNAs as cis-acting regulators of transcription factor-encoding genes in IgA nephropathy.
    PLoS One. 2024;19:e0304301.
    >> Share

  118. CREMER T, Hoelen H, van de Weijer ML, Janssen GM, et al
    Proinsulin degradation and presentation of a proinsulin B-chain autoantigen involves ER-associated protein degradation (ERAD)-enzyme UBE2G2.
    PLoS One. 2024;19:e0287877.
    >> Share

  119. COBB J, Rawson J, Gonzalez N, Orr C, et al
    Reversal of diabetes by an oral Salmonella-based vaccine in acute and progressive diabetes in NOD mice.
    PLoS One. 2024;19:e0303863.
    >> Share

  120. REBALKA IA, Noguchi KS, Bulyovsky KR, Badour MI, et al
    Targeting skeletal muscle health with exercise in people with type 1 diabetes: A protocol for HOMET1D, a prospective observational trial with matched controls.
    PLoS One. 2024;19:e0303448.
    >> Share

  121. JEONG C, Baek H, Bae J, Hwang N, et al
    Gut microbiome in the Graves' disease: Comparison before and after anti-thyroid drug treatment.
    PLoS One. 2024;19:e0300678.
    >> Share

  122. HARRISON DM, Allette YM, Zeng Y, Cohen A, et al
    Meningeal contrast enhancement in multiple sclerosis: Assessment of field strength, acquisition delay, and clinical relevance.
    PLoS One. 2024;19:e0300298.
    >> Share

  123. DUAN P, Tian S
    Mendelian randomization analyses reveal no genetic causal effects of major adipokines on systemic lupus erythematosus.
    PLoS One. 2024;19:e0301699.
    >> Share

  124. EKELUND C, Dereke J, Nilsson C, Landin-Olsson M, et al
    Are soluble E-selectin, ICAM-1, and VCAM-1 potential predictors for the development of diabetic retinopathy in young adults, 15-34 years of age? A Swedish prospective cohort study.
    PLoS One. 2024;19:e0304173.
    >> Share

  125. BALDASSO BD, Raza SZ, Islam SS, Burry IB, et al
    Disrupted hemodynamic response within dorsolateral prefrontal cortex during cognitive tasks among people with multiple sclerosis-related fatigue.
    PLoS One. 2024;19:e0303211.
    >> Share

  126. BAXTER F, Baillie N, Dover A, Stimson RH, et al
    A cross-sectional questionnaire study: Impaired awareness of hypoglycaemia remains prevalent in adults with type 1 diabetes and is associated with the risk of severe hypoglycaemia.
    PLoS One. 2024;19:e0297601.
    >> Share

  127. STEFANOVIC M, Jovanovic I, Zivkovic M, Stankovic A, et al
    Pathway analysis of peripheral blood CD8+ T cell transcriptome shows differential regulation of sphingolipid signaling in multiple sclerosis and glioblastoma.
    PLoS One. 2024;19:e0305042.
    >> Share

  128. ALMUTAIRI FF
    The feasibility of point shear wave elastography (pSWE) in the assessment of pancreas stiffness in diabetic patients and healthy volunteers.
    PLoS One. 2024;19:e0303098.
    >> Share

  129. CHI G, Pei J, Li X
    Inflammatory bowel disease and risk of autoimmune hepatitis: A univariable and multivariable Mendelian randomization study.
    PLoS One. 2024;19:e0305220.
    >> Share

  130. SERATA EL, Noonan EJ, Petersen KH
    Barriers to USMLE Step-1 accommodations: Students with Type 1 Diabetes.
    PLoS One. 2024;19:e0304784.
    >> Share

  131. HE L, He W
    Clinicopathologic features and outcomes of bilateral lacrimal gland lesions.
    PLoS One. 2024;19:e0305717.
    >> Share

  132. GEBREMESKEL GG, Haile TG, Gebrewahd GT, Hailay A, et al
    Effectiveness of non-pharmacological therapies for chronic pain in people with autoimmune diseases in Africa: A protocol for a systematic review and meta-analysis.
    PLoS One. 2024;19:e0306564.
    >> Share

  133. LI Z, Jia B, Guo Z, Zhang K, et al
    Therapeutic potential of salidroside in type I diabetic erectile dysfunction: Attenuation of oxidative stress and apoptosis via the Nrf2/HO-1 pathway.
    PLoS One. 2024;19:e0306926.
    >> Share

  134. PIKULIN S, Yehezkel I, Moskovitch R
    Enhanced blood glucose levels prediction with a smartwatch.
    PLoS One. 2024;19:e0307136.
    >> Share

  135. SUMIMOTO H, Noda S, Koide H, Douke Y, et al
    Pre-existing autoimmune disease as a risk factor for immune-related adverse events in cancer patients receiving immune checkpoint inhibitors.
    PLoS One. 2024;19:e0306995.
    >> Share

  136. CAMPANIONI S, Veiga C, Prieto-Gonzalez JM, Gonzalez-Novoa JA, et al
    Explainable machine learning on baseline MRI predicts multiple sclerosis trajectory descriptors.
    PLoS One. 2024;19:e0306999.
    >> Share

  137. YAMADA K, Tanabe A, Hashimoto M, Ohsugi M, et al
    A single-center retrospective study on the clinical features of thyrotoxic periodic paralysis.
    PLoS One. 2024;19:e0308076.
    >> Share

  138. WANG YY, Ying HM, Tian F, Qian XL, et al
    Three months use of Hybrid Closed Loop Systems improves glycated hemoglobin levels in adolescents and children with type 1 diabetes: A meta-analysis.
    PLoS One. 2024;19:e0308202.
    >> Share

  139. KIM N, Kim S, Choi JR, Park Y, et al
    Evaluation of autoimmune liver disease antibodies in hepatitis patients.
    PLoS One. 2024;19:e0307285.
    >> Share

  140. LI B, Zhang L, Li Q, Zhang J, et al
    Multiple sclerosis and abnormal spermatozoa: A bidirectional two-sample mendelian randomization study.
    PLoS One. 2024;19:e0308815.
    >> Share

  141. LEE MJ, Verma R, Hamilton BE, Pettersson D, et al
    The utility of orbital imaging in the evaluation of orbital disease.
    PLoS One. 2024;19:e0308528.
    >> Share

  142. CHAIPRASERT A, Han P, Laomettachit T, Ruengjitchatchawalya M, et al
    Network analysis retrieving bioactive compounds from Spirulina (Arthrospira platensis) and their targets related to systemic lupus erythematosus.
    PLoS One. 2024;19:e0309303.
    >> Share

  143. KAKUCS Z, Illes Z, Hayden Z, Berki T, et al
    Osteopontin predicts late-time salience network-related functional connectivity in multiple sclerosis.
    PLoS One. 2024;19:e0309563.
    >> Share

  144. WEISE S, Du Y, Heidemann C, Baumert J, et al
    Diabetes self-management education programs: Results from a nationwide population-based study on characteristics of participants, rating of programs and reasons for non-participation.
    PLoS One. 2024;19:e0310338.
    >> Share

  145. D'ALESSANDRO M, Cameli P, Cotton CV, Lamb JA, et al
    Panel of serum biomarkers for differential diagnosis of idiopathic interstitial lung disease and interstitial lung disease-secondary to systemic autoimmune rheumatic disease.
    PLoS One. 2024;19:e0311357.
    >> Share

  146. CAMBOULIVE L, Grandhomme F, Martin Silva N, Khoy K, et al
    Clinical impact of ceruloplasmin levels at ANCA-associated vasculitis diagnosis.
    PLoS One. 2024;19:e0311678.
    >> Share

  147. MAGEAU A, Geradin C, Sallah K, Papo T, et al
    Risk of systemic lupus erythematosus flare after COVID-19 hospitalization: A matched cohort study.
    PLoS One. 2024;19:e0309316.
    >> Share

  148. BUIANOVA A, Yukina M, Cheranev V, Suchalko O, et al
    Trio-based exome sequencing and high-resolution HLA typing in families of patients with autoimmune adrenal insufficiency and autoimmune polyglandular syndrome.
    PLoS One. 2024;19:e0312335.
    >> Share

  149. SOKRATOUS D, Charalambous CC, Zamba-Papanicolaou E, Michailidou K, et al
    A 12-week in-phase bilateral upper limb exercise protocol promoted neuroplastic and clinical changes in people with relapsing remitting multiple sclerosis: A registered report randomized single-case concurrent multiple baseline study.
    PLoS One. 2024;19:e0299611.
    >> Share

  150. SABOYA-GALINDO P, Mejia-Salgado G, Cifuentes-Gonzalez C, Rodriguez-Rodriguez CA, et al
    Uveitis characteristics and multiple sclerosis phenotype of patients with multiple sclerosis-associated uveitis: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0307455.
    >> Share

  151. KOVACEVIC S, Zdravkovic V, Blagojevic J, Djordjevic S, et al
    Association of variants in AGTR1, ACE, MTHFR genes with microalbuminuria and risk factors for the onset of diabetic nephropathy in adolescents with type 1 diabetes in the population of Serbia.
    PLoS One. 2024;19:e0312489.
    >> Share

  152. GIRAUD E, Fiette L, Melanitou E
    Type 1 diabetes and parasite infection: An exploratory study in NOD mice.
    PLoS One. 2024;19:e0308868.
    >> Share

  153. TISELL A, Soderberg K, Link Y, Lundberg P, et al
    Diffuse white matter pathology in multiple sclerosis during treatment with dimethyl fumarate-An observational study of changes in normal-appearing white matter using proton magnetic resonance spectroscopy.
    PLoS One. 2024;19:e0309547.
    >> Share

  154. FABER W, Stillebroer AB
    Addressing bladder and bowel challenges in dutch multiple sclerosis patients: Symptom prevalence and patient referral pathways.
    PLoS One. 2024;19:e0310691.
    >> Share

  155. NAFARI A, Vaheb S, Afshari-Safavi A, Ravankhah Z, et al
    Cancer and mortality risks among people with multiple sclerosis: A population-based study in Isfahan, Iran.
    PLoS One. 2024;19:e0312707.
    >> Share

  156. LI Y, Kong D, Ding Y, Wang J, et al
    The potential impact of COVID-19 vaccination on patients with immune thrombocytopenic purpura: A protocol for systematic review and meta-analysis.
    PLoS One. 2024;19:e0308546.
    >> Share

  157. IAQUINTO S, Ineichen BV, Salmen A, Kuhle J, et al
    Factors associated with low health-related quality of life in persons with multiple sclerosis: A quantile-based segmentation approach.
    PLoS One. 2024;19:e0312486.
    >> Share

  158. DE LA CRUZ A, Garces M, Larios E, Madera-Salcedo IK, et al
    Immune complex deposition promotes NK cell accumulation in the kidney.
    PLoS One. 2024;19:e0312141.
    >> Share

  159. MARIC GD, Pekmezovic TD, Tamas OS, Veselinovic ND, et al
    Investigation of differences between chronological and vascular age in persons with multiple sclerosis.
    PLoS One. 2024;19:e0311117.
    >> Share

  160. RIVERA-FRANCO N, Lopez-Alvarez D, Castillo A, Aristizabal E, et al
    Genomic variability in Zika virus in GBS cases in Colombia.
    PLoS One. 2024;19:e0313545.
    >> Share

  161. NAJMI EA, Mirzaasgari Z, Motamed MR, Aslani A, et al
    Carotid intima-media thickness and risk of atherosclerosis in multiple sclerosis: A cross-sectional study.
    PLoS One. 2024;19:e0314031.
    >> Share

  162. SALEEM O, Iqbal J
    Blood-glucose regulator design for diabetics based on LQIR-driven Sliding-Mode-Controller with self-adaptive reaching law.
    PLoS One. 2024;19:e0314479.
    >> Share

  163. ZURRER WE, Cannon AE, Ewing E, Bruschweiler D, et al
    STEED: A data mining tool for automated extraction of experimental parameters and risk of bias items from in vivo publications.
    PLoS One. 2024;19:e0311358.
    >> Share

  164. MIRMOSAYYEB O, Yazdan Panah M, Mokary Y, Mohammadi M, et al
    Neuroimaging markers and disability scales in multiple sclerosis: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0312421.
    >> Share

  165. CHEIBCHALARD T, Leelahavanichkul A, Chatthanathon P, Klankeo P, et al
    Fungal microbiome in gut of systemic lupus erythematosus (SLE)-prone mice (pristane and FCGRIIb deficiency), a possible impact of fungi in lupus.
    PLoS One. 2024;19:e0314662.
    >> Share

  166. TSUNODA R, Kume K, Kagawa R, Sanuki M, et al
    Machine-learning-based identification of patients with IgA nephropathy using a computerized medical billing database.
    PLoS One. 2024;19:e0312915.
    >> Share

  167. RASOULI S, Dakkali MS, Ghazvini A, Azarbad R, et al
    Predictive model for converting optic neuritis to multiple sclerosis; decision tree in focus.
    PLoS One. 2024;19:e0309702.
    >> Share

  168. DESCHAMPS N, Nacher M, Preux PM, Takam V, et al
    Pattern, causes and functional outcome of peripheral neuropathies in the Amazon region.
    PLoS One. 2024;19:e0315760.
    >> Share

  169. SHRIWASH N, Aiman A, Singh P, Basir SF, et al
    Understanding the role of potential biomarkers in attenuating multiple sclerosis progression via multiomics and network-based approach.
    PLoS One. 2024;19:e0314428.
    >> Share

  170. LEE JY, Lee SB, Yang SW, Paik JS, et al
    Linsitinib inhibits IGF-1-induced cell proliferation and hyaluronic acid secretion by suppressing PI3K/Akt and ERK pathway in orbital fibroblasts from patients with thyroid-associated ophthalmopathy.
    PLoS One. 2024;19:e0311093.
    >> Share

  171. KOOSHKI A, Farmani R, Amirabadizadeh A, Mehrpour O, et al
    Essential and toxic metal concentrations in biological samples of multiple sclerosis patients: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0313851.
    >> Share

  172. BIGDELI A, Ghaderi-Zefrehei M, Lesch BJ, Behmanesh M, et al
    Bioinformatics analysis of myelin-microbe interactions suggests multiple types of molecular mimicry in the pathogenesis of multiple sclerosis.
    PLoS One. 2024;19:e0308817.
    >> Share

    January 2023
  173. TEKIN H, Frobert O, Graesli AR, Kindberg J, et al
    Hibernation and plasma lipids in free-ranging brown bears-implications for diabetes.
    PLoS One. 2023;18:e0291063.
    >> Share

  174. LIN DY, Andreotti AH
    Structure of BTK kinase domain with the second-generation inhibitors acalabrutinib and tirabrutinib.
    PLoS One. 2023;18:e0290872.
    >> Share

  175. MONSTED MO, Holm LJ, Buschard K, Haupt-Jorgensen M, et al
    Failure to replicate the diabetes alleviating effect of a maternal gluten-free diet in non-obese diabetic mice.
    PLoS One. 2023;18:e0289258.
    >> Share

  176. HOWLAND S, Huber J, Aicken C
    Designing a brief and simple intervention to help young people with type 1 diabetes to live well: Protocol for developing a novel intervention with participation from young people.
    PLoS One. 2023;18:e0285300.
    >> Share

  177. SIKORSKI P, Li Y, Cheema M, Wolfe GI, et al
    Serum metabolomics of treatment response in myasthenia gravis.
    PLoS One. 2023;18:e0287654.
    >> Share

  178. POLICK CS, Ploutz-Snyder R, Braley TJ, Connell CM, et al
    Fatigue, pain interference, and psychiatric morbidity in multiple sclerosis: The role of childhood stress.
    PLoS One. 2023;18:e0292233.
    >> Share

  179. PHAM HN, Pham L, Sato K
    Bioinformatic analysis identified novel candidate genes with the potentials for diagnostic blood testing of primary biliary cholangitis.
    PLoS One. 2023;18:e0292998.
    >> Share

  180. PARK SS, Mai M, Ploszaj M, Cai H, et al
    Type 1 diabetes contributes to combined pulmonary fibrosis and emphysema in male alpha 1 antitrypsin deficient mice.
    PLoS One. 2023;18:e0291948.
    >> Share

  181. O'MALLEY N, Coote S, Staunton FM, O'Connor E, et al
    A core outcome set for evaluating the effectiveness of mixed-diagnosis falls prevention interventions for people with Multiple Sclerosis, Parkinson's Disease and stroke.
    PLoS One. 2023;18:e0294193.
    >> Share

  182. KRAKENES T, Wergeland S, Al-Sharabi N, Mohamed-Ahmed S, et al
    The neuroprotective potential of mesenchymal stem cells from bone marrow and human exfoliated deciduous teeth in a murine model of demyelination.
    PLoS One. 2023;18:e0293908.
    >> Share

  183. ABIDOV M, Sokolova K, Danilova I, Baykenova M, et al
    Hepatic insulin synthesis increases in rat models of diabetes mellitus type 1 and 2 differently.
    PLoS One. 2023;18:e0294432.
    >> Share

  184. CHENG CW, Fang WF, Lin JD
    Associations of serum keratin 1 with thyroid function and immunity in Graves' disease.
    PLoS One. 2023;18:e0289345.
    >> Share

  185. SUZUKI K, Iwata D, Namba K, Hase K, et al
    Involvement of Angiopoietin 2 and vascular endothelial growth factor in uveitis.
    PLoS One. 2023;18:e0294745.
    >> Share

  186. WALLE M, Arkew M, Asmerom H, Tesfaye A, et al
    The diagnostic accuracy of mean platelet volume in differentiating immune thrombocytopenic purpura from hypo-productive thrombocytopenia: A systematic review and meta-analysis.
    PLoS One. 2023;18:e0295011.
    >> Share

  187. ZHOU Q, Xiong Z, Yang D, Xiong C, et al
    The association between bullous pemphigoid and cognitive outcomes in middle-aged and older adults: A systematic review and meta-analysis.
    PLoS One. 2023;18:e0295135.
    >> Share

  188. HARVENGT AA, Polle OG, Martin M, van Maanen A, et al
    Post-Hypoglycemic hyperglycemia are highly relevant markers for stratification of glycemic variability and partial remission status of pediatric patients with new-onset type 1 diabetes.
    PLoS One. 2023;18:e0294982.
    >> Share

  189. TRENTIN-SONODA M, Cheff V, Gutsol A, Hebert RL, et al
    Sex-dependent effects of Canagliflozin on kidney protection in mice with combined hypertension-type 1 diabetes.
    PLoS One. 2023;18:e0295284.
    >> Share

  190. LORD SM, Bahnson HT, Greenbaum CJ, Liljenquist DR, et al
    Testing a new platform to screen disease-modifying therapy in type 1 diabetes.
    PLoS One. 2023;18:e0293268.
    >> Share

  191. FALLAH M, Najafi A, Balighi K, Daneshpazhooh M, et al
    Association of alternative healthy eating index and severity of pemphigus vulgaris: A cross-sectional study.
    PLoS One. 2023;18:e0295026.
    >> Share

  192. ABDULLAHI AS, Suliman A, Khan MA, Khair H, et al
    Temporal trends of hemoglobin among pregnant women: The Mutaba'ah study.
    PLoS One. 2023;18:e0295549.
    >> Share

  193. WILF-YARKONI A, Feldmann K, Rubarth K, Dorsch EM, et al
    Effectiveness of oral prednisone tapering following intravenous methylprednisolone for acute optic neuritis in multiple sclerosis.
    PLoS One. 2023;18:e0288366.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016